Logo image
Back
When to Assess Responses to Treatments in Adaptive Interventions? An Experimental Analysis of Assessment Timing in a Smoking Cessation Treatment in the Context of Lung Cancer Screening
Journal article   Peer reviewed

When to Assess Responses to Treatments in Adaptive Interventions? An Experimental Analysis of Assessment Timing in a Smoking Cessation Treatment in the Context of Lung Cancer Screening

Rina Horii, Alexander J. Rothman, David M. Vock, Anne M. Joseph, Mariah Branson, Anne C. Melzer, Abbie Begnaud and Steven S. Fu
Nicotine & tobacco research
02/02/2026
DOI: 10.1093/ntr/ntag021
PMID: 41626753

View Online

Abstract

Introduction The Program for LUng cancer screening and TObacco (PLUTO) cessation trial was a sequential, multiple assignments, randomized trial to optimize the delivery of tobacco longitudinal care (TLC), and a 1-year telephone coaching and combination nicotine replacement therapy program. Our analyses tested the effects of the randomized response assessment timepoint. Methods Participants who smoked daily and were eligible for lung cancer screening (n = 636) were randomized to have their response to treatment assessed after 4 or 8 weeks of TLC. Participants' responses determined whether they could be randomized to more (TLC with prescription medication therapy management, MTM) or less (TLC delivered quarterly) intensive treatment for the remainder of the trial. We used chi-squares and generalized linear models to test whether assessment timing affected 7-day point prevalence abstinence at weeks 12, 26, 52, and 78. Results Participants who were assessed at week 4, rather than 8, were more likely to report abstinence at weeks 12 and 26 (ORs > 1.48, p's < 0.034). Among participants who were smoking at week 4, early assessment was associated with higher abstinence at weeks 12-52 (ORs > 1.31, p's < 0.019), and there was some evidence at weeks 12 and 52 that it was better to offer MTM earlier rather than later (ORs > 1.27, p's < 0.057). Conclusions Earlier treatment response assessment may be beneficial, especially for those who are not responsive to initial treatment, but more research is needed to understand the mechanisms, generalizability, and robustness of the effect.
 Substance Abuse Life Sciences & Biomedicine Public, Environmental & Occupational Health Science & Technology

Details

Metrics

1 Record Views
Logo image